Rigel Pharmaceuticals, Inc.
Historical 13F Holders
Symbol
RIGL
CUSIP
766559702
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period
Filings
Shares, Excl. Options
Value, Excl. Options
Options Value
2025 Q1
125
14.0 M
$252 M
$878 k
2024 Q4
122
12.1 M
$203 M
$1.18 M
2024 Q3
96
11.9 M
$193 M
$9.32 M
2024 Q2
90
11.8 M
$97.2 M
$6.77 M